Patent details

Basic Information

Publication number:

EP3304086

PCT Application Number:

JP2016002562

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP168027902

PCT Publication Number:

WO2016194348

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

METHOD FOR PREDICTING RESPONSIVENESS TO A COMBINATION THERAPY WITH LENVATINIB AND EVEROLIMUS

French Title of Invention:

MÉTHODE POUR PRÉDIRE LA RÉACTIVITÉ À UNE THÉRAPIE COMBINÉE AVEC DU LENVATINIB ET DE L'ÉVÉROLIMUS

German Title of Invention:

METHODE ZUR VORHERSAGE DES ANSPRECHENS AUF EINE KOMBINATIONSTHERAPIE MIT LENVATINIB UND EVEROLIMUS

SPC Number:

Dates

Filing date:

27/05/2016

Grant date:

23/12/2020

EP Publication Date:

11/04/2018

PCT Publication Date:

08/12/2016

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

23/12/2020

EP B1 Publication Date:

23/12/2020

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

27/05/2021

Expiration date:

27/05/2036

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

16/12/2020

 

 

Name:

Eisai R&D Management Co., Ltd.

Address:

4-6-10 Koishikawa Bunkyo-ku, Tokyo 112-8088, Japan (JP)

Inventor

1

Name:

FUNAHASHI, Yasuhiro

Address:

Japan (JP)

2

Name:

KADOWAKI, Tadashi

Address:

Japan (JP)

Priority

Priority Number:

201562167964 P

Priority Date:

29/05/2015

Priority Country:

United States (US)

Classification

IPC classification:

A61P 13/12; A61P 35/00; G01N 33/574;

Publication

European Patent Bulletin

Issue number:

202052

Publication date:

23/12/2020

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages